WebmedCentral Editor
View all WebmedCentral Editors
No Image

Dr. Srikanth Ranganathan

Scientific Advisor
Ideon Science Park

Brief Biography:

Srikanth Ranganathan completed his Bachelors and Master of Science degrees at Bangalore University, India. He then obtained a second MS degree from the Georgia Institute of Technology, Atlanta, USA before a stint spanning 5 years at the Wilmer Eye Institute and Kennedy Krieger Institute, Johns Hopkins Medical Institutions, Baltimore, USA working on aspects including cell signaling in gliomas. Later on, he pursued a doctoral degree from University of Pittsburgh working on molecular mechanisms in Amyotrophic lateral sclerosis (ALS) and Alzheimer's disease. He published his thesis entitled "ALS - From molecular mechanisms to biomarker discovery" having done SELDI-TOF based biomarker work in ALS CSF. Thereafter, he went on to do two post-doctoral fellowships studying molecular mechanisms of motor neuron diseases, polyglutamine diseases, and movement disorders. The first fellowship was at the National Institute of Neurological Disorders and Stroke, NIH, Bethesda, USA with Prof. Kenneth Fischbeck and the second at the Wallenberg Neuroscience Center at Lund University, Lund Sweden with Prof. Patrik Brundin. Currently he serves as a Chief Scientific Advisor at the Ideon Science Park in Lund, Sweden. 


Academic positions:

Scientific Advisor to the Chairman, Farstorp Invest AB

Senior Post-doctoral Associate, Neuroscience, Lunds Universitet, Sweden

Post-doctoral Fellow, Neurogenetics, National Institutes of Health, USA

Ph.D., Cellular and Molecular Pathology, University of Pittsburgh, USA

MS., Biology, Georgia Institute of Technology, USA

M.Sc., Zoology, Bangalore University, India


Research interests:

Disease mechanisms of neurological disorders and neurodegenerative diseases, Translational research, Endocrinology, Mitochondrial biology, and Metabolic syndromes


What I think of the idea behind WebmedCentral:

I think it is a wonderful idea because I strongly believe that Science should be in the public domain with open peer review.